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Andres Schanzer, MD, Worcester, Mass
Objective: Endovascular aortic repair (EVAR) has gained wide acceptance for the elective treatment of abdominal aortic
aneurysms (AAA), leading to interest in similar treatment of ruptured abdominal aortic aneurysms (RAAA). The purpose
of this study was to evaluate national outcomes after EVAR for RAAA and to assess the effect of institutional volume
metrics.
Methods: The Nationwide Inpatient Sample was used to identify patients treated with open or EVAR for RAAA,
2001-2006. Procedure volume was determined for each institution categorizing hospitals as low-, medium-, and
high-volume. The primary outcome was in-hospital mortality. Secondary outcomes related to resource utilization.
Multivariable logistic regression models were used to determine independent predictors of EVAR usage and
mortality.
Results: From 2001 to 2006, an estimated 27,750 hospital discharges for RAAA occurred; 11.5% were treated with
EVAR. EVAR utilization increased over time (5.9% in 2001 to 18.9% in 2006, P < .0001) while overall RAAA rates
remained constant. EVAR had a lower overall in-hospital mortality than open repair (31.7% vs 40.7%, P < .0001), an
effect which amplified when stratified by institutional volume. On multivariable regression, open repair independently
predicted mortality (odds ratio [OR] 1.56; 95% confidence interval [CI] 1.29-1.89). EVAR usage for RAAA increased
with age (>80 years) (OR 1.58; 95% CI 1.30-1.93), high elective EVAR volume (>40/y) vs medium (19-40/y) (OR
2.65; 95% CI 1.86-3.78) and low (<19/y) (OR 5.37; 95% CI 3.60-8.0). EVAR had a shorter length of stay (11.1 vs 13.8
days, P < .0001), higher discharges to home (65.1% vs 53.9%, P < .0001), and lower charges ($108,672 vs $114,784,
P < .0001).
Conclusions: In theUnited States, for RAAA, EVAR had a lower postoperative mortality than open repair. Higher elective
open repair as well as RAAA volume increased this mortality advantage for EVAR. These results support regionalization
of RAAA repair to high volume centers whenever possible and a wider adoption of endovascular repair of RAAA
nationwide. (J Vasc Surg 2009;49:817-26.)Since endovascular aortic repair (EVAR) was initially
reported by Parodi in 1991,1 the use of EVAR for elective
abdominal aortic aneurysm (AAA) repair has gained in-
creasing popularity. The minimally invasive nature of this
technique, as well as the demonstrated reduction in 30
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doi:10.1016/j.jvs.2008.11.002day2,3,4 morbidity and mortality rates, have contributed to
the rapid adoption of this new technology. The successful
application of EVAR for elective AAA repair has led to an
increasing interest in expanding its role in patients presenting
with ruptured abdominal aortic aneurysms (RAAA).
Rupture of an AAA portends a dismal prognosis. Most
patients do not survive long enough to reach medical care4
and, for those who do survive and undergo traditional open
repair, the reported mortality rate continues to exceed
40%.5,6,7 Given these poor outcomes after open RAAA
repair, as well as the reduction in perioperative morbidity
and mortality seen after elective EVAR, some centers have
established protocols to use EVAR for patients with RAAA.
Recently, Mehta and colleagues demonstrated excellent
results after implementation of such a protocol, with re-
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Mastracci and colleagues, who report an aggregate 21%
mortality rate for RAAA treated with EVAR, have corrob-
orated these results in a systematic review.9
We therefore sought to determine the frequency with
which EVAR is used to repair RAAA on a national level and
to investigate three primary endpoints: (1) predictors of
EVAR use for the treatment of RAAA, (2) postoperative
mortality rates for EVAR and open repair, and (3) resource
utilization. We also evaluated the relationship between
hospital aortic aneurysm repair volume and the RAAA
mortality rate at individual centers. We hypothesize that
EVAR of ruptured aortic aneurysms is performed with
lower mortality and lower resource utilization than open
repair.
METHODS
The Nationwide Inpatient Sample (NIS) from 2001 to
200610 was utilized to evaluate operative outcomes associ-
ated with RAAA at the national level. The NIS is the largest
representative database of inpatient hospital discharges,
derived from an annual national survey of 20% of nonfed-
eral United States hospitals. It contains all-payer data and is
supported by the Healthcare Cost and Utilization Project
(HCUP). The NIS provides a validated weighting strategy
in order to allow estimates to be drawn at the national level.
Because the statistical calculations are based on these
weighted frequencies, the data reported in this study are
provided in weighted format; this technique is consistent
with prior reports.11,12
We assembled a study cohort of patients undergoing
RAAA repair using diagnostic and procedural codes from
the International Classification of Diseases Ninth Revision,
Clinical Modification (ICD9-CM).13 Patients were identi-
fied by linking the diagnostic codes for RAAA (441.3;
441.30) with the procedure codes for either open aortic
repair (38.44; 39.25) or endovascular aortic repair (39.71).
Patients who did not undergo either open or endovascular
surgical intervention were excluded. We intentionally ex-
cluded all years prior to 2001 because the specific
ICD9-CM code for EVAR was not available until October
of 2000. Additionally, we specifically excluded all patients
with an ICD9-CM code for intact AAA (441.4) in order to
focus the analysis on RAAA.
Patient level factors analyzed included age, gender,
race, insurance type, and comorbid medical conditions
(using the Elixhauser comorbid technique, designed for
use with administrative datasets14). Hospital level factors
were obtained by directly linking the NIS to the American
Hospital Association’s Annual Survey ofHospitals.10 These
factors included hospital size (number of inpatient beds),15
teaching status, and location (rural vs urban).
Hospital volume designations. Three variables were
created to describe yearly hospital surgical volume: elective
open aneurysm volume, elective EVAR volume, and total
RAAA volume (repair by open or EVAR). Annual institu-
tional volume was calculated by dividing the total number
of procedures performed at a given institution by thenumber of years in which the institution was included in the
survey. Institutional volume was divided into tertiles in
order to maintain similar group numbers for each volume
stratum prior to any statistical analysis, as has been previously
described in other volume-based analyses.16 For elective open
aneurysm repair annual volume, low volume centers per-
formed less than 13 repairs, medium volume centers per-
formed 13 to 29 repairs, and high volume centers performed
more than 29 repairs. For elective EVAR annual volume, low
volume centers performed less than 19 repairs, medium vol-
ume centers performed 19 to 40 repairs, and high volume
centers performed more than 40 repairs. For RAAA annual
volume (regardless of repair type), low volume centers per-
formed less than three repairs, medium volume hospitals
performed three to six repairs, and high volume centers per-
formed more than six RAAA repairs.
Study endpoints. The primary endpoint in this cross-
sectional study was in-hospital mortality, defined as a post-
operative death from any cause prior to hospital discharge
(regardless of time from the index procedure). Secondary
outcomes, pertaining to hospital resource utilization,
were length of hospital stay, hospital charges, incidence
of adjunctive procedures (feeding tube or tracheos-
tomy), and disposition at time of discharge (home vs
rehabilitation facility, skilled nursing facility, nursing
home, or other).
Statistical analyses were performed using SAS version
9.1 (Cary, NC). Univariate analysis was performed by t test
for continuous variables and by Rao-Scott 2 for categorical
variables. Trend analyses were performed using theMantel-
Haenszel 2 test. Multivariable logistic regression models
were utilized to identify independent predictors of RAAA
mortality and to identify independent determinants of the
procedure type selected for the treatment of RAAA (EVAR
vs open). All tests were considered statistically significant at
an alpha level of .05 (P  .05, two-tailed).
RESULTS
Overall patient characteristics. The mean age of the
entire cohort was 73.1 years; 26% were older than 80 years
of age. Overall, 77% of patients were men and 89% of
patients were white. Comorbid medical conditions were
common in this population, with 68% of patients having at
least one documented comorbid condition. The majority
of patients (70%) were treated at the largest hospitals in
their geographic region.
A comparison of the characteristics between the open
and EVAR repair groups revealed significant differences
between the two groups included older age in the EVAR
group (P .0001) and a corresponding greater percentage
of octogenarians (P  .0001). In addition, the RAAA
patients treated with EVARweremore likely to have certain
pre-existing comorbidities, specifically, renal failure (P 
.01), hypertension (P  .02), and liver disease (P  .02).
The two groups were similar in terms of gender, race, the
total number of comorbid conditions, and insurance type
(P  .05 for all), Table I.
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RAAA repair was evaluated according to elective open AAA
repair volume, elective EVAR volume, and total RAAA
volume. From 2001 to 2006, an estimated 27,750 pa-
tients underwent repair of RAAA. Overall, open aneu-
rysm repair was utilized with far greater frequency than
EVAR, representing 88.5% of RAAA repairs. Nonethe-
less, over the 6-year study period, despite the relatively
unchanged incidence of aneurysm rupture, the percent-
age of patients undergoing EVAR for RAAA increased
from 5.9% in 2001 to 18.9% in 2006 (P .0001 by trend
Table I. Comparison of open and endovascular repairs of
2001-2006
Open
Weighted size n (%) 24,571 (88.5)
Characteristics
Mean age, y [SEM] 73.0 [0.13]
80-y-old (%) 6020 (24.5)
Male (%) 18,958 (77.2)
Race (%)
Non-white 1946 (11.0)
White 15,797 (89.0)
Comorbidities
Renal failure 1892 (7.7)
CHF 702 (2.9)
DM 2123 (8.6)
Chronic lung disease 8466 (34.5)
HTN 9106 (37.1)
Obesity 889 (3.6)
Liver disease 210 (0.9)
Comorbid conditions
No comorbidity 7978 (32.5)
1-3 comorbidities 15,686 (63.9)
3 comorbidities 907 (3.7)
Insurance type
Private/Medicare 23,108 (94.1)
Medicaid/self-pay 1438 (5.2)
Hospital bedsize
Small 1779 (7.3)
Medium 5762 (23.5)
Large 16,997 (69.3)
Hospital type (%)
Teaching 12,329 (50.2)
Non-teaching 12,209 (49.8)
Hospital location (%)
Urban 22,514 (91.8)
Rural 2024 (8.2)
Elective open AAA volume
Low (13/y) 11,528 (46.9)
Medium (13-29/y) 7220 (29.4)
High (29/y) 5822 (23.7)
Elective EVAR volume
Low (19/y) 17,013 (69.2)
Medium (19-40/y) 4563 (18.6)
High (40/y) 2995 (12.2)
Ruptured AAA volume
Low ( 3/y) 8202 (33.4)
Medium (3-6/y) 9934 (40.4)
High (6/y) 6434 (26.2)
EVAR, Endovascular aortic repair; AAA, abdominal aortic aneurysms; CHtest, Fig 1).The volume of elective open AAA repairs performed by
an institution did not significantly impact utilization rates
of EVAR for RAAA by univariate analysis (Fig 2, a). In
contrast, higher volume elective EVAR centers treated a
significantly higher percentage of RAAA patients with
EVAR (27.3 % vs 12.6% vs 7.6%, P  .0001) (Fig 2, b).
Similarly, higher volume RAAA centers also treated a sig-
nificantly higher percentage of RAAA patients with EVAR
(14.3% vs 11.6% vs 8.9%, P  .02) (Fig 2, c).
Independent determinants of EVAR usage in pa-
tients with RAAA. Multivariable logistic regression mod-
ured abdominal aortic aneurysms in the United States,
EVAR Total P value
3179 (11.5) 27,750 (100)
74.3 [0.43] 73.1 [0.12] .0001
1065 (33.5) 7085 (25.5) .0001
2436 (76.6) 21,394 (77.1) .76
.12
320 (13.6) 2266 (11.3)
2023 (86.4) 17,819 (88.7)
340 (10.7) 2232 (8.0) .01
66 (2.1) 768 (2.8) .25
312 (9.8) 2434 (8.8) .39
1055 (33.2) 9521 (34.3) .54
1325 (41.7) 10,431 (37.6) .02
119 (3.8) 1008 (3.6) .86
56 (1.8) 266 (0.96) .02
.05
879 (27.7) 8857 (31.9)
2163 (68.0) 17,849 (64.3)
137 (4.3) 1044 (3.8)
.81
2996 (94.4) 26,104 (94.2)
178 (5.6) 1617 (5.8)
.15
255 (8.0) 2034 (7.3)
585 (18.4) 6347 (22.9)
2339 (73.6) 19,336 (70.0)
.0001
2196 (69.1) 14,524 (52.4)
983 (30.9) 13,193 (47.6)
.17
3008 (94.6) 25,522 (92.1)
171 (5.4) 2195 (7.9)
0.34
1404 (44.2) 12,932 (46.6)
867 (27.2) 8087 (29.1)
908 (28.6) 6731 (24.3)
.0001
1394 (43.8) 18,407 (66.3)
660 (20.8) 5223 (18.8)
1125 (35.4) 4120 (14.9)
.02
800 (25.2) 9002 (32.4)
1306 (41.1) 11,240 (40.5)
1073 (33.7) 7507 (27.1)
gestive heart failure; DM, diabetes mellitus; HTN, hypertension.rupt
F, conels that included patient characteristics, hospital character-
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constructed to identify independent predictors of EVAR
utilization in patients with RAAA (Table II). Adjusting
for all other variables in the model, institutions in the
high volume tertile (40/y) for elective EVAR were
more likely to use EVAR for RAAA than were the
medium tertile (19-40/y) institutions (odds ratio [OR]
2.65; 95% confidence interval [CI] 1.86-3.78) and the
low tertile (19/y) institutions (OR 5.37; 95% CI 3.6-
8.0). Other factors that were independently predictive of
EVAR usage for RAAA included age 80 years (OR
1.58; 95% CI 1.30-1.93), treatment at a teaching hospi-
tal (OR 1.85; 95% CI 1.40-2.45), or being treated in the
year 2006 vs 2001 (OR 2.96; 95% CI 2.01-4.36). Con-
versely, a significant negative predictor by multivariate
regression of EVAR usage for RAAA was high volume of
open elective AAA repair: the high volume tertile
(29/y) open elective AAA centers were less likely to
utilize EVAR for RAAA than the medium tertile (13-
29/y) centers (OR .72; 95% CI .50-1.03) and the low
tertile (13/y) centers (OR .36; 95% CI .23-.57).
Postoperative mortality following RAAA repair
evaluated according to elective open AAA repair vol-
ume, elective EVAR volume, and total RAAA volume.
The overall crude mortality following operative repair of
ruptured AAA was 40.7% for open repair and 31.7% for
EVAR, P  .0001 (Fig 3).
Elective open AAA repair volume. The low volume
elective open AAA institutions (13/y) had similar mor-
tality for RAAA for both EVAR and open repair (39.3% vs
43.9%, P  .13). Similarly, at the medium volume elective
open AAA institutions (13-29/y), EVAR for ruptured
aneurysm repair was associated with a similar mortality to
open repair (32.1% vs 38.3%, P  .14). In contrast, at the
high volume open elective AAA centers (29/y), the
mortality was significantly lower for EVAR than for open
repair (19.7% vs 37.2%, P  .0001) (Fig 4, a).
Elective EVAR volume. At the centers performing a
Fig 1. Procedures performed for ruptured AAA, 2001-2006.low annual volume of elective EVAR (19/y), the mortal-ity after repair of a RAAA was similar for both EVAR and
open repair (41.1% vs 41.3%, P  .95). Institutions in the
medium volume tertile for the number of elective EVAR
procedures (19-40) demonstrated significantly lower
RAAA mortality rates with EVAR than with open repair
(27% vs 40.6%, P  .003). The difference in postopera-
tive mortality rates was even greater at the centers per-
forming a high annual volume of elective endovascular
aneurysm repairs (40/y), where the postoperative
mortality rates after endovascular repair for aneurysm
rupture (22.9%) were 14% less than that for open repair
(37.1%), P  .0001 (Fig 4, b).
Total RAAA volume. At the institutions performing
the lowest annual volume of ruptured AAA repairs (3/y),
the postoperative mortality rate after both EVAR and open
repair was similarly in excess of 40%, P  .64. At centers
performing a medium annual volume of ruptured AAA
repairs (3-6/y), EVAR patients had a lower postoperative
mortality rate than open repair (31.2% vs 40.5%, P .008).
Similarly, at the centers performing the highest annual
volume of ruptured AAA repairs (6/y), the postoperative
mortality rate after EVAR was significantly lower than after
open repair, (22.3% vs 37.4%, P  .0001) (Fig 4, c).
Independent determinants of mortality after RAAA
repair. Multivariable logistic regression models that in-
cluded patient characteristics, hospital characteristics, vol-
ume metrics, and procedure year were constructed to iden-
tify independent predictors of mortality in patients with
RAAA (Table III). Adjusting for all other variables in the
model, open repair of RAAA was associated with a signifi-
cantly higher mortality than EVAR (OR 1.56; 95% CI
1.29-1.89). Likewise, low volume of open elective AAA
was associated with higher mortality (OR 1.24; 95% CI
1.01-1.52). Other independent predictors of mortality in-
clude female gender (OR 1.41; 95% CI 1.23-1.61), age
80 years (OR 1.95; 95% CI 1.72-2.22) and treatment at
a non-teaching hospital (OR 1.24; 95% CI 1.08-1.43).
Resource utilization. Following the repair of RAAA,
patients who underwent EVAR had significantly shorter
mean hospital length of stay than those undergoing open
repair (11.1 days vs 13.8 days, P  .0001). Similarly, a
significantly larger proportion of patients treated with
EVAR were discharged directly to home than those under-
going open repair (65.1% vs 53.9%, P  .0001). Open
repair of RAAAwas associated with an increased percentage
of adjunctive procedures during the index hospitalization,
including tracheostomy placement (5.2% vs 2.9%, P .01)
and feeding tube placement (4.6% vs 2.7%, P  .03). With
regards to mean total hospital charges, EVAR had lower
expenditures than open repair ($108,672 vs $114,784, P
.0001) (Table IV).
DISCUSSION
This study shows that while the incidence of RAAA
between 2001 and 2006 remained fairly constant, EVAR
was used to treat RAAA in an increasing proportion of
patients (from 5.9% in 2001 to 18.9% in 2006). Indepen-
dent predictors of the use of EVAR for the treatment of
e.
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EVAR volume, and treatment at a teaching institution.
Endovascular repair of RAAAwas independently associated
with a lower postoperative mortality risk than was open
repair (OR 1.56, CI 1.29-1.89), and the reduction in
postoperative mortality was strongly related to the institu-
tional volume of elective AAA repairs. Additionally, pa-
tients undergoing EVAR demonstrated lower resource uti-
lization than those undergoing open repair.
The finding in the current study that an increasing
percentage of patients with RAAA were treated with EVAR
during the study period correlates well with previous find-
ings from the NIS and from other population-based data-
sets. Using statewide data from California, Florida, New
Jersey, and New York (approximately one-third of US
population), Greco et al found that the percentage of
patients undergoing EVAR for RAAA increased from 0.3%
to 6.3% between 2000 and 2003.17 L’Esperance et al, in a
recent report based on data from the NIS also noted an
increasing trend toward EVAR usage from 6% in 2001 to
11% by 2004.18 The current study may more accurately
reflect national trends than the regional report of Greco
et al. Similarly, the NIS, unlike Medicare data, incorporates
all-payer information and therefore included patients less
than 65 years of age and uninsured patients (6% of total); it
also incorporates more rural regions such as the Midwest
and Southern United States. Additionally, this study ex-
tends the findings of L’Esperance and colleagues by ex-
tending the analysis to 2006 (the most recent available
Fig 2. A, Procedure type performed for RAAA based on
performed for RAAA based on annual elective EVAR in
based on annual RUPTURED AAA institutional volumdata) and by explicitly investigating predictors of EVARuse, RAAA repair associated mortality, and resource utili-
zation.
We observed a lower mortality rate after EVAR for
treatment of RAAA than after open repair on both univar-
iate and multivariable analysis. Previous authors have sug-
gested that annual hospital surgical volume may contribute
to outcomes following RAAA repair. L’Esperance et al did
not explicitly include a volume analysis, but hypothesized
that hospital volume likely contributed to their observed
differences between teaching and non-teaching institu-
tions.18 A volume analysis by Greco et al also found that
greater elective and non-elective AAA volume was associ-
ated with lower mortality following AAA rupture.17 On
univariate analysis, we found a clear mortality advantage
directly related to all volume measures analyzed: annual
elective open repair volume, annual elective EVAR volume,
and annual RAAA volume. For each of these metrics,
mortality decreased significantly as annual surgical volume
increased. The absolute mortality benefit was most pro-
nounced when analyzed according to elective EVAR vol-
ume; institutions in the high elective EVAR volume tertile
(40/y) had an absolute mortality decrease of 15% (Fig
4, b). This volume outcome relationship has been clearly
demonstrated in the elective AAA setting,19,20 however,
the volume impact on outcomes following repair of RAAA
has been heretofore limited. Unfortunately due to the
de-identified patient information and administrative nature
of this dataset, comprehensive clinical information is un-
available. Conclusions drawn from this work should be
ive OPEN AAA institutional volume. B, Procedure type
ional volume. C, Procedure type performed for RAAAelect
stitutmade with the understanding that an unmeasured selection
F, con
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may not have been considered for endovascular manage-
ment. However, depending on the comfort level of the
surgeon and institutional experience with EVAR, it is fea-
Table II. Multivariable analysis of the predictors of EVAR
Factor Odds
Patient characteristics
Men (vs women) 1.1
Age group
80 (vs 80) 1.5
Comorbid conditions
CHF (vs none) .6
Hypertension (vs none) 1.1
Chronic lung disease (vs none) 1.0
Liver disease (vs none) 1.7
Renal failure (vs none) 1.3
Diabetes (vs none) 1.1
Comorbid groups
3 comorbidities (vs none) 1.0
3 comorbidities (vs 1-3) .9
Insurance type
Medicaid/self-pay (vs private) 1.0
Year of procedure
2006 (vs 2001) 2.9
Hospital characteristics
Annual elective open AAA volume
High (29/y) vs medium (13-29/y) .7
High (29/y) vs low (13/y) .3
Annual elective EVAR volume
High (40/y) vs medium (19-40/y) 2.6
High (40/y) vs low (19/y) 5.3
Annual ruptured AAA volume
High (6/y) vs medium (3-6/y) .9
High (6/y) vs low (3/y) .9
Bed size
Large (vs small) 1.1
Medium (vs small) .9
Hospital location
Urban (vs rural) 1.3
Teaching status
Teaching (vs non-teaching) 1.8
EVAR, Endovascular aortic repair; AAA, abdominal aortic aneurysms; CH
Fig 3. Overall In-hospital mortality by procedure type for RAAA.sible that some unstable patients may still have been treatedby endovascular means as was the case in 25% of patients in
the EVAR arm of the work from the Albany Medical
Center.8
The absence of significant independent effects of
EVAR volume and RAAA volume on mortality deserves
special comment. This finding may be related to our study
design which involved the creation of three distinct volume
categories for each procedure examined (elective EVAR,
elective open, RAAA). This analytic design assigned three
different volume designations to each single institution.
For example, it was possible for a single institution to be
designated a high volume EVAR institution and a high
volume open institution, while also a low volume RAAA
institution. Because all volume characteristics were in-
cluded in the multivariate regression, the effects of a single
volume characteristic may be attenuated due to colinearity
with another volume characteristic of the same institution.
To test for this effect, we performed a separate analysis
where each volume metric was included in the regression
separately. On these analyses, each low volume designation
was independently predictive of increased mortality, con-
treatment of ruptured AAA
95% confidence interval P
.91-1.37 .30
1.30-1.93 .0001
.33-1.22 .17
.88-1.57 .29
.77-1.34 .92
.74-4.04 .21
.98-1.94 .07
.77-1.60 .59
.98
.46-2.33
.55-1.79
.99
.69-1.47
2.01-4.36 .0001
.0001
.50-1.03
.23-.57
.0001
1.86-3.78
3.60-8.0
.83
.68-1.25
.67-1.44
.37
.78-1.78
.6-1.46
.26
.83-2.03
.0001
1.4-2.45
gestive heart failure.for
ratio
1
8
3
7
1
3
8
1
3
9
0
6
2
6
5
7
2
8
8
4
5firming a colinearity effect.
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hospital surgical volume characteristics, teaching hospitals
continued to show lower mortality risks following RAAA
repair than non-teaching hospitals. This finding is similar to
the conclusions of L’Esperance et al who identified a sur-
vival advantage for EVAR at teaching hospitals but did not
specifically assess or control for surgical volumemeasures in
their analysis.18 In our study, this overall survival advantage
in favor of teaching hospitals persisted after volume adjust-
ment. While we recognize that this survival advantage at
teaching hospitals is likely multifactorial, we believe that
even low volume centers may benefit from the presence of
a specific vascular surgical liaison (resident/fellow) “on the
ground,” in order to expeditiously triage and oversee the
timely transfer of critically ill patients to the computed
tomography (CT) scanner or operating room, depending
on the degree of cardiovascular compromise.
Previous authors have shown that establishment of a
multidisciplinary ruptured AAA protocol maximizes the
ability to perform EVAR in an emergent fashion in both
hemodynamically stable and unstable patients.8,21 In a
single institution report from the Albany Medical Center
(n  85), Mehta and colleagues found that following the
implementation of a protocol for EVAR for RAAA, the
mean time to the operating room from a presumptive
diagnosis of RAAA was 20 minutes, with an overall mortal-
ity rate of 18%.8 They attributed their success to maintain-
ing an adequate inventory of available stent grafts, surgeon
comfort with EVAR in the elective setting, and the practice
Fig 4. A, In-hospital mortality of RAAA by procedure
in-hospital mortality of RAAA based on elective EVAR in
RAAA annual institutional volume.of “hypotensive hemostasis” (minimizing volume resusci-tation and tolerating hypotension as long as the patient
maintained a detectable blood pressure only, in an effort to
minimize ongoing hemorrhage). Our national findings
support their institutional observations, in that high vol-
ume elective EVAR centers had a fivefold increase in odds
of using EVAR in a ruptured AAA setting, with a mortality
rate as low as 20%. This finding may relate to the greater
ability of high volume EVAR centers to stock a diverse array
of endograft options, thereby facilitating emergency usage.
In addition, high volume EVAR centers are more likely to
have available an endovascular surgeon with greater tech-
nical fluency in endovascular therapies.
In our opinion, the current and previous findings,
within the limitations of studies derived from administra-
tive datasets including the potential for selection bias in
favor of EVAR, may serve as an impetus for hospitals to
establish RAAA protocols to maximize the potential for
EVAR usage when appropriate. Institutions at which EVAR
protocols for RAAA are not feasible may consider the imple-
mentation of systems by which appropriate patients can be
rapidly transferred to institutionswithEVARcapabilities. This
concept was underscored by the Albany medical center group
in which more than one-third of the study patients were
transferred from an outside institution.8 This suggests that,
although critically ill, a substantial number of RAAA patients
may be candidates for transfer to higher volume EVAR insti-
tutions.
In terms of resource utilization between the two pro-
cedures, the statistical significance observed may be of
based on elective open AAA institutional volume. B,
ional volume.C, in-hospital mortality of RAAA based ontype
stitutlimited clinical or practical significance. Both procedure
F, con
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April 2009824 McPhee et altypes were associated with total hospital charges greater
than $100,000 and the average length of stay was greater
than ten days for both procedures. The detailed character-
istics of specific costs of the two procedures would best be
evaluated by an in-depth cost analysis between both proce-
dure types. The current dataset is limited to overall hospital
Table III. Multivariable analysis of the predictors of mort
Factor Odds r
Patient characteristics
Women (vs men) 1.4
Age group
80 (vs 80) 1.9
Comorbid conditions
CHF (vs none) .8
Hypertension (vs none) .7
Chronic lung disease (vs none) .7
Liver disease (vs none) 3.3
Renal failure (vs none) 1.0
Diabetes (vs none) 1.1
Comorbid groups
3 comorbidities (vs none) .8
3 comorbidities (vs 1-3) 1.1
Insurance type
Medicaid/self-pay (vs private) .8
Year of procedure
2006 (vs 2001) 1.0
Procedure type
Open repair (vs EVAR) 1.5
Hospital characteristics
Annual elective open AAA volume
Low (13/y) vs high (29/y) 1.2
Medium (13-29/y) vs high (29/y) 1.0
Annual elective EVAR volume
Low (19/y) vs high (40/y) 1.0
Medium (19-40/y) vs high (40/y) 1.2
Annual ruptured AAA volume
Low (3/y) vs high (6/y) 1.0
Medium (3-6/y) vs high (6/y) 1.0
Bed size
Large (vs small) .8
Medium (vs small) .9
Hospital location
Rural (vs urban) 1.2
Teaching status
Non-teaching (vs teaching) 1.2
EVAR, Endovascular aortic repair; AAA, abdominal aortic aneurysms; CH
Table IV. EVAR vs open AAA resource utilization
Open
Additional surgical procedures
Tracheostomy (%) 5.2
Feeding tube (%) 4.6
Mean length of stay (d) 13.8
Discharge disposition
Discharged to home (%) 53.9
Discharged to rehab/other (%) 46.1
Mean hospital charges $114,784
EVAR, Endovascular aortic repair; AAA, abdominal aortic aneurysms.charge information and therefore specific cost factors at-tributable directly to the procedure itself or related compli-
cations are unavailable in this type of study.
Our study design faces several of the limitations that are
inherent to any work utilizing large administrative data-
sets.22,23 First, coding inaccuracies relating to patient fac-
tors, hospital characteristics, or outcomes may exist includ-
for treatment of ruptured AAA
95% confidence interval P
1.23-1.61 .0001
1.72-2.22 .0001
.57-1.23 .35
.6-.87 .0005
.62-.89 .001
1.94-5.78 .0001
.84-1.37 .6
.92-1.48 .2
.02
.48-1.44
.73-1.66
.65-1.1 .14
.85-1.29 .12
1.29-1.89 .0001
.09
1.01-1.52
.91-1.32
.19
.85-1.32
.96-1.49
.95
.84-1.25
.86-1.22
.09
.64-1.04
.73-1.19
.08
.97-1.54
.003
1.08-1.43
gestive heart failure.
EVAR Overall P value
2.9 4.9 .01
2.7 4.4 .03
11.1 13.5 .0001
.0001
65.1 55.4
34.9 44.6
$108,672 $114,316 .0001ality
atio
1
5
3
2
4
5
7
7
3
3
5
6
4
9
6
3
3
1
3
2
4ing the apparently protective effect of certain chronic
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Volume 49, Number 4 McPhee et al 825medical conditions. This observation was appreciated by
previous authors and found that likely a bias against the
coding of chronic medical conditions in patients that die in
the hospital accounts for this phenomenon to some de-
gree.24 In this study, these coding errors are expected to
equally affect open aneurysm repair patients and EVAR
patients, and therefore are unlikely to introduce significant
bias in comparing the two procedures.
Second, because the NIS dataset excludes several
important clinical factors, we were not able to control for
possible selection bias favoring the use of EVAR for more
stable patients. These missing factors include, but are not
limited to, imaging data pertaining to aortic anatomy,
hemodynamic status on arrival to the hospital, laboratory
data, and time delay to diagnosis. We attempted to
compensate for these limitations by using previously
validated comorbidity software,14 and by including all of
the comorbidity variables in the multivariable regression
models. However, this methodology cannot completely
capture the severity of every individual patient’s comor-
bid disease state.
Finally, while the primary study outcome, in-hospital
mortality, is an important and reliable endpoint, it by no
means captures all of the elements necessary to judge
treatment success. The rigorous patient de-identification
process employed by the NIS to protect patient confiden-
tiality precludes the analysis of longitudinal clinical data.
Therefore, it was impossible to evaluate other equally im-
portant outcomes, such as long-term morbidity and mor-
tality, need for secondary interventions, and quality of life
indices.
CONCLUSION
An increasing proportion of patients presenting with
RAAA in the United States were treated by EVAR between
2001 and 2006. The strongest predictor of the use of
EVAR for RAAA repair is elective EVAR institutional vol-
ume. At the national level, within the confines of adminis-
trative datasets including a likely unmeasured selection bias,
EVAR was found to have a significantly lower national
mortality rate than the open repair of RAAA. The region-
alization of RAAA to high volume EVAR institutions,
when feasible, may serve to decrease the in-hospital mor-
tality rate for this critically ill patient population.
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